Orthofix Medical Inc.
OFIXUS売上高
$822M
百万USD
営業利益
$-81M
百万USD
純利益
$-92M
百万USD
ROE
-20.5%
最新FY
EPS
$-2.33
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $106M | $-6M | $-0.30 |
| FY2021 | Q2 | $121M | $2M | $0.12 |
| FY2021 | Q3 | $112M | $-2M | $-0.11 |
| FY2021 | FY | $464M | $-38M | $-1.95 |
| FY2022 | Q1 | $106M | $-4M | $-0.22 |
| FY2022 | Q2 | $118M | $2M | $0.12 |
| FY2022 | Q3 | $114M | $-11M | $-0.53 |
| FY2022 | FY | $461M | $-20M | $-0.98 |
| FY2023 | Q1 | $175M | $-61M | $-1.71 |
| FY2023 | Q2 | $187M | $-39M | $-1.07 |
| FY2023 | Q3 | $184M | $-29M | $-0.77 |
| FY2023 | FY | $747M | $-151M | $-4.12 |
| FY2024 | Q1 | $189M | $-36M | $-0.95 |
| FY2024 | Q2 | $199M | $-33M | $-0.88 |
| FY2024 | Q3 | $197M | $-27M | $-0.71 |
| FY2024 | FY | $799M | $-126M | $-3.30 |
| FY2025 | Q1 | $194M | $-53M | $-1.35 |
| FY2025 | Q2 | $203M | $-14M | $-0.36 |
| FY2025 | Q3 | $206M | $-23M | $-0.57 |
| FY2025 | FY | $822M | $-92M | $-2.33 |
| FY2026 | Q1 | $197M | $-21M | $-0.52 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $453M | $460M | $407M | $464M | $461M | $747M | $799M | $822M |
| 営業利益 | $21M | $41M | $30M | $-19M | $-6M | $-8M | $-13M | $-139M | $-85M | $-81M |
| 純利益 | $3M | $6M | $14M | $-28M | $3M | $-38M | $-20M | $-151M | $-126M | $-92M |
| 総資産 | $372M | $405M | $467M | $496M | $526M | $477M | $459M | $925M | $893M | $851M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $263M | $297M | $335M | $328M | $357M | $337M | $337M | $599M | $503M | $450M |
| 営業CF | $45M | $53M | $50M | $32M | $74M | $18M | $-12M | $-46M | $26M | $33M |
| EPS | $0.17 | $0.34 | $0.72 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.30 | $-2.33 |
| BPS | $14.68 | $16.12 | $17.60 | $17.08 | $18.29 | $16.97 | $9.24 | $16.01 | $12.89 | $11.21 |
| ROE | 1.2% | 2.1% | 4.1% | -8.7% | 0.7% | -11.4% | -5.9% | -25.3% | -25.0% | -20.5% |